|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��ԭ��,ɳ�� |
|
���в�ѧ |
| ��������������� | |
|
��ʡ |
|
������ |
| PubMed | |
|
Article by |
|
Article by |
ɳ����ԭ��������в�ѧ�о���չ
��ʡ, ������
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о��� �Ͼ� 210042
���ɳ����ԭ�岻ͬ��λ�Ļ����⼼�����źܸ������Ժ�������,Ϊ�������в�ѧ���о��ṩ����Ч�Ĺ��ߡ�Ŀǰɳ����ԭ��������в�ѧ�о���������������ͬ����������Ⱥ�͵����ϵķֲ����о���������ɳ����ԭ�崫��������,���һ�����̽�ֲ�ͬ������ɳ����ԭ�����ٴ�֢״�ͼ�����Ĺ�ϵ,�Ӷ���Ч�Ŀ�չɳ����ԭ���Ԥ���Ϳ��ơ�
[2] Sturm-Ramirez K, Brumblay H, Diop K, et al. Molecular epidemiology of genital Chlamydia trachomatis infection in high-risk women in Senegal, West Africa. J Clin Microbiol, 2000, 38:138-145.
[3] Anttila T, Saikku P, Koskela P, et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma.JAMA, 2001, 285:47-51.
[4] Piot P, Islam MQ. Sexually transmitted diseases in the 1990s. Global epidemiology and challenges for control. Sex Transm Dis, 1994, 21:S7-S13.
[5] Paavonen J, Puolakkainen M, Paukku M, et al. Cost-benefit analysis of first-void urine Chlamydia trachomatis screening program. Obstet Gynecol, 1998, 92:292-298.
[6] Word Health Organization Department of HIV/AIDS. Global prevalence and incidence of selected curable sexually transmitted infections. Overview and estimates. Geneva: Wrrld Health Organization,2001:10-13.
[7] Kukita Y, Higasa K, Baba S, et al. A single-strand conformation polymorphism method for the large-scale analysis of mutations/polymorphisms using capillary array electrophoresis. Electrophoresis, 2002,23: 2259-2266.
[8] Bronham R, Yang C, Maclean I, et al. Chlamydia trachomatis from individuals in a sexually transmitted disease core group exhibit frequent sequence variation in the major outer membrane protein (omp1)gene. J Clin Invest, 1994, 94:458-463.
[9] Thomas NS, Lusher M, Storey CC, et al. Plasmid diversity in Chlamydia. Microbiology, 1997, 143:1847-1854.
[10] Pedersen LN, Kjaer HO, Moiler JK, et al. High-resolution genotyping of Chlamydia trachomatis from recurrent urogenital infections. J Clin Microbiol, 2000, 38:3068-3071.
[11] Jonsdottir K, Kristjansson M, Hjaltalin Olafsson J, et al. The molecular epidemiology of genital Chlamydia trachomatis in the greater Reykjavik area, Iceland. Sex Transm Dis, 2003, 30:249-256.
[12] Crotchfelt KA, Pare B, Gaydos C, et al. Detection of Chlamydia traehomatis by the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women. J Clin Microbiol, 1998, 36:391-394.
[13] Morre SA, Sillekens P, Jacobs MV, et al. RNA amplification by nucleic acid sequence-based amplification with an internal standard enables reliable detection of Chlamydia trachomatis in cervical scrapings and urine samples. J Clin Microbiol, 1996, 34:3108-3114.
[14] Morre SA, Ossewaarde JM, Lan J, et al. Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovars Ba,G, and J as confirmed by ompl nueleotide sequence analysis. J Clin Microbiol, 1998, 36:345-351.
[15] Choi TY, Kim DA, Seo YH. Evaluation of serotyping using monoclonal antibodies and PCR-RFLP for Chlamydia trachomatis serotype identification. J Korean Med Sci, 2001, 16:15-19.
[16] Goessens WH, Mouton JW, van der Meijden WI, et al. Comparison of three commercially available amplification assays, AMP CT, LCx,and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine. J Clin Microbiol, 1997, 35:2628-2633.
[17] Somani J, Bhullar VB, Workowski KA, et al. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis, 2000, 181:1421-1427.
[18] Bandea CI, Kubota K, Brown TM, et al. Typing of Chlamydia trachomatis strains from urine samples by amplification and sequencing the major outer membrane protein gene (ompl). Sex Transm Infect,2001, 77:419-422.
[19] Jurstrand M, Falk L, Fredlund H, et al. Characterization of Chlamydia trachomatis ompl genotypes among sexually transmitted disease patients in Sweden. J Clin Microbiol, 2001, 39:3915-3919.
[20] Cabral T, Jolly AM, Wylie JL. Chlamydia trachomatis omp1 genotypic diversity and concordance with sexual network data. J Infect Dis,2003, 187:279-286.
[21] Wylie JL, Jolly A. Patterns of chlamydia and gonorrhea infection in sexual networks in Manitoba, Canada. Sex Transm Dis, 2001, 28:14-24.
[22] Brunham RC. Core group theory: a central concept in STD epidemiology. Venereology, 1997, 10:34-39.
[23] van Duynhoven YT, Ossewaarde JM, Derksen-Nawrocki RP, et al.Chlamydia trachomatis genotypes: correlation with clinical manifestations of infection and patients' characteristics. Clin Infect Dis, 1998,26:314-322.
[24] Dean D, Oudens E, Bolan G, et al. Major outer membrane protein variants of Chlamydia trachomatis are associated with severe upper genital tract infections and histopathology in San Francisco. J Infect Dis, 1995, 172:1013-1022.
[25] Morre SA, Rozendaal L, van Valkengoed IG, et al. Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations?J Clin Microbiol, 2000, 38:2292-2296.
[26] Zenilman JM. Chlamydia and cervical cancer: a real association? JAMA, 2001, 285:81-83.
[27] Marrazzo JM, White CL, Krekeler B, et al. Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay.Ann Intern Med, 1997, 127:796-803.